Difficulty: Medium
Average Score: 68%
Practice
A 46-year-old male patient has Cushing's syndrome that is due to the presence of an adrenal tumor. Which of the following drugs would be expected to reduce the signs and symptoms of this man's disease?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Ketoconazole. Ketoconazole is an antifungal medication that also has the ability to inhibit adrenal steroidogenesis. In the case of a patient with Cushing's syndrome caused by an adrenal tumor, the excessive production of cortisol by the adrenal gland contributes to the signs and symptoms of the disease. By inhibiting steroidogenesis, Ketoconazole can help reduce the levels of cortisol in the body, thereby alleviating the manifestations of Cushing's syndrome.
Option A) Betamethasone is a corticosteroid medication that would exacerbate the symptoms of Cushing's syndrome by adding more exogenous cortisol to the body.
Option B) Cortisol is the hormone that is already elevated in Cushing's syndrome, so providing more cortisol would not be beneficial in reducing the signs and symptoms.
Option C) Fludrocortisone is a synthetic corticosteroid that primarily affects mineralocorticoid activity and would not address the excess cortisol production seen in Cushing's syndrome.
Educationally, understanding the mechanism of action of medications used in endocrine disorders is crucial for healthcare providers to make informed decisions in patient care. Knowing the specific effects of each drug allows for tailored treatment plans that target the underlying pathophysiology of the condition, leading to better patient outcomes.
Option A) Betamethasone is a corticosteroid medication that would exacerbate the symptoms of Cushing's syndrome by adding more exogenous cortisol to the body.
Option B) Cortisol is the hormone that is already elevated in Cushing's syndrome, so providing more cortisol would not be beneficial in reducing the signs and symptoms.
Option C) Fludrocortisone is a synthetic corticosteroid that primarily affects mineralocorticoid activity and would not address the excess cortisol production seen in Cushing's syndrome.
Educationally, understanding the mechanism of action of medications used in endocrine disorders is crucial for healthcare providers to make informed decisions in patient care. Knowing the specific effects of each drug allows for tailored treatment plans that target the underlying pathophysiology of the condition, leading to better patient outcomes.